join our newsletter
Close Window
join our newsletter
Click here to print. << Back to All Newsletters
Study finds cannabis effective for treating depression
NCBI.NLM.NIH.gov
Click here to go to the external website that hosts this news story.
OUR TAKEAWAY
According to a new study published in the Yale Journal of Biology and Medicine, dried cannabis flower consumption significantly reduces symptoms of depression and works much faster than pharmaceutical antidepressants
Microdoses of THC are optimal for pain relief, say cannabis researchers
TheGrowthOP.com
Click here to go to the external website that hosts this news story.
OUR TAKEAWAY
“Israeli med-tech company Syqe Medical has conducted the first clinical trial to demonstrate that extremely low and precise doses of inhaled THC – the principal psychoactive constituent of cannabis – can effectively relieve pain, while avoiding the common side effects associated with cannabis use.”
How marijuana laws complicate scientists' search for crucial answers about cannabis, hemp
DemocratandChronicle.com
Click here to go to the external website that hosts this news story.
OUR TAKEAWAY
With cannabis still designated as a Schedule I controlled substance, many researchers are restricted in scope by federal regulations governing the psychoactive chemical THC. “There’s a lot of evidence that could be gathered and it’s just not being done. We desperately need research,” said Arthur Fougner, president of the Medical Society of the State of New York.
Science reveals the cannabis industry's greatest myth: you're buying weed wrong (and so is everyone else)
Forbes.com
Click here to go to the external website that hosts this news story.
OUR TAKEAWAY
In today’s legal, recreational cannabis market, two factors - price and THC content - tend to influence what the consumer decides to buy, but recent research has begun to show that THC content is a poor indicator of product quality and potency. As more scientific research occurs and the general consumer becomes more educated, there are several new factors that may ultimately drive cannabis purchasing decisions.
'Dabbers' of cannabis concentrate display effects similar to pot smokes, despite elevated THC
ColoState.edu
Click here to go to the external website that hosts this news story.
OUR TAKEAWAY
“New results from a Colorado study indicate that inhaling cannabis concentrates, or 'dabbing,' doesn’t affect a person’s balance or sense of being 'high' any more than smoking the flower form of the drug, despite causing high levels of THC in the blood. The findings could lead to eventual changes in how law enforcement uses roadside sobriety tests to determine whether a driver is under the influence of cannabis."
<< Back to All Newsletters

The Momentum of Cannabis: July 3, 2020

Cannabis is already legal in 33 states, and more than half of the U.S. population has access to the plant in some shape or form. Today there are almost 250,000 legal cannabis industry jobs in the United States. This year legal cannabis will generate nearly $1.5 billion in federal tax revenue. Now, with the arrival of a global pandemic, the industry's performance has lent credence to the growing notion that cannabis may be recession-proof and could be a boon to beleaguered budgets. Total U.S. retail sales fell 21.6% in April from the previous year, yet cannabis sales in several states posted significant sales gains."The momentum of cannabis" continues to build...

CONTINUE READING